Famotidine Prices: Chart, Market Analysis, Price Trends, Regional Outlook and Forecast 2026

Author : ChemAnalyst Data | Published On : 12 Oct 2026

According to ChemAnalyst, The global Famotidine prices recorded modest upward pressure during the second quarter of 2026, primarily influenced by increasing freight expenses, higher shipping insurance costs, and adjustments in landed import values. While pharmaceutical demand remained relatively stable across major consuming regions, logistics-related cost changes played an important role in shaping quarterly price movements. North America and Asia-Pacific (APAC) reported moderate increases in their Famotidine Price Index, whereas the European market remained broadly stable amid predictable import flows and consistent pharmaceutical procurement.

Famotidine is an active pharmaceutical ingredient (API) widely used in medicines that reduce stomach acid production. It belongs to the histamine H2-receptor antagonist category and is commonly associated with the treatment of conditions such as heartburn, acid reflux, and peptic ulcers. Its continued use in prescription and over-the-counter formulations supports demand from pharmaceutical manufacturers, distributors, and healthcare procurement networks.

During Q2 2026, the Famotidine price trend reflected a market in which transportation costs and import-related expenses had a greater influence on pricing than significant changes in underlying demand. Buyers continued to assess supplier quotations, freight charges, insurance premiums, and delivery schedules to manage procurement costs. Regional differences in sourcing structures and import dependence also contributed to variations in average quarterly prices.

Famotidine Prices in North America

United States Famotidine Price Trend in Q2 2026

In the United States, the Famotidine Price Index increased by 1.75% quarter-over-quarter during Q2 2026, with the average Famotidine price reaching approximately USD 58,549.33/MT. The increase was primarily attributed to recent freight cost increases, which raised landed expenses for imported pharmaceutical ingredients and placed moderate upward pressure on supplier offers.

The US market relies on a combination of domestic pharmaceutical manufacturing capabilities and international supply chains for APIs and pharmaceutical intermediates. Consequently, changes in international freight rates can influence the final procurement costs faced by pharmaceutical companies, particularly when imported material represents a substantial share of their sourcing requirements.

During the quarter, higher transportation expenses contributed to the increase in the average Famotidine price. Even when supplier manufacturing costs remain relatively stable, changes in ocean freight, insurance, handling, and port-related charges can affect the delivered cost of pharmaceutical ingredients. These expenses are especially relevant for buyers operating under fixed procurement budgets or negotiating supply agreements with limited flexibility for logistics adjustments.

Demand from pharmaceutical manufacturers and distributors remained an important underlying market factor. Famotidine is used in a range of oral formulations, including tablets and other products designed to manage excess stomach acid. Procurement activity is therefore influenced by medicine production schedules, inventory requirements, and replenishment cycles across pharmaceutical distribution networks.

However, the 1.75% quarterly increase suggests that pricing pressure remained moderate rather than reflecting a substantial market disruption. Buyers could continue managing costs through supplier diversification, advance purchasing, shipment consolidation, and negotiations over freight-inclusive quotations.

Get Real Time Online for Famotidine Prices: https://www.chemanalyst.com/Pricing-data/famotidine-2540

Factors Influencing Famotidine Prices in the US

Several factors shaped the US Famotidine price trend during the second quarter of 2026:

Freight cost increases: Higher transportation expenses raised the landed cost of imported Famotidine and contributed to quarterly price growth.
Import-related expenses: Shipping insurance, port handling, and other logistics charges affected the final procurement cost.
Pharmaceutical manufacturing demand: API purchasing remained linked to production requirements for prescription and over-the-counter medicines.
Supplier negotiations: Buyers evaluated quotations from alternative suppliers to limit the impact of rising delivered costs.
Inventory management: Stock levels and purchasing schedules influenced the timing of new orders and the extent to which higher logistics expenses were passed through to buyers.

Overall, the US Famotidine market experienced a moderate increase in Q2 2026. The direction of prices reflected additional landed-cost pressure, while stable underlying pharmaceutical demand helped prevent more pronounced fluctuations.

Famotidine Prices in APAC

China Famotidine Price Trend in Q2 2026

In China, the Famotidine Price Index increased by 1.75% quarter-over-quarter during Q2 2026, with the average quarterly price reaching approximately USD 58,402.67/MT. The increase was mainly associated with higher freight insurance costs, which contributed to the pass-through of additional logistics expenses into supplier quotations and delivered prices.

China is an important participant in the pharmaceutical ingredients supply chain, supported by its manufacturing infrastructure, chemical processing capabilities, and established export networks. For buyers sourcing Famotidine from Chinese suppliers, the final procurement cost can depend on manufacturing expenses, order volumes, export logistics, insurance arrangements, and destination-market requirements.

During the quarter, higher freight insurance costs contributed to a modest upward movement in the Famotidine price trend. Although the increase was not particularly sharp, additional logistics expenses affected the economics of cross-border transactions. Exporters and importers had to account for changes in shipment-related costs when negotiating delivery terms and final quotations.

The Chinese market also operates within a competitive pharmaceutical manufacturing environment. Buyers generally evaluate supplier reliability, product specifications, manufacturing consistency, documentation, and pricing before finalizing contracts. As a result, higher freight-related costs may be passed through differently depending on the supplier's contractual arrangements and the destination of the shipment.

Pharmaceutical manufacturers continued to represent a key source of demand for Famotidine. Purchasing activity remained connected to formulation requirements, inventory replenishment, and the need to maintain consistent supplies of pharmaceutical ingredients. For export-oriented suppliers, demand conditions in overseas markets can also affect order visibility and shipment planning.

The 1.75% increase in China's Famotidine Price Index indicates that transportation and insurance expenses were meaningful influences on quarterly pricing. Nevertheless, the available market figures point to a moderate adjustment rather than an abrupt change in the broader supply-demand balance.

Factors Influencing Famotidine Prices in China

The principal influences on the Chinese Famotidine market during Q2 2026 included:

Freight insurance costs: Higher insurance expenses increased the total cost of international shipments.
Export logistics: Transportation, handling, and delivery arrangements influenced the final price paid by overseas buyers.
Manufacturing competitiveness: Supplier competition and production efficiency continued to shape commercial quotations.
International demand: Export orders and pharmaceutical production schedules influenced procurement activity.
Contractual pricing: The extent of cost pass-through depended on delivery terms, shipment responsibilities, and existing supply agreements.

Looking ahead, China's Famotidine price direction will depend on the interaction between manufacturing conditions, international order volumes, and transportation costs. A reduction in freight-related expenses could ease pressure on export prices, while renewed increases in logistics costs could continue to influence landed values.

Famotidine Prices in Europe

Germany Famotidine Price Trend in Q2 2026

In Germany, Famotidine prices remained broadly stable quarter-over-quarter during the second quarter of 2026. Unlike the US and Chinese markets, where the Famotidine Price Index increased by 1.75%, the German market experienced limited overall price movement. Predictable import flows and steady over-the-counter (OTC) and hospital procurement supported market stability.

Germany's pharmaceutical supply chain is influenced by established distribution networks, regulated medicine procurement, and quality requirements for pharmaceutical ingredients. Buyers typically assess supplier qualifications, product specifications, documentation, delivery reliability, and total procurement costs when purchasing APIs for pharmaceutical production.

During Q2 2026, relatively consistent import availability helped limit significant changes in Famotidine prices. Stable procurement from pharmaceutical manufacturers, distributors, and healthcare-related supply channels also supported a balanced market environment. When import schedules remain predictable and buyers can plan replenishment in advance, sudden purchasing pressure is less likely to develop.

Nevertheless, the German market was not entirely insulated from logistics-related cost changes. Freight normalization and modest insurance adjustments created some movement in landed costs, even as the overall quarterly price trend remained stable. These changes could influence individual supplier quotations or contracts without producing a substantial shift in the average market price.

The balance between stable procurement demand and manageable import expenses helped maintain pricing consistency. Buyers continued to focus on dependable supply, quality compliance, and cost control rather than responding to significant price volatility.

Factors Supporting Price Stability in Germany

Several market conditions contributed to the stability of Famotidine prices in Germany:

Predictable import flows: Consistent shipment schedules helped maintain a reliable supply of pharmaceutical ingredients.
Steady OTC and hospital procurement: Ongoing demand from established pharmaceutical and healthcare channels supported regular purchasing activity.
Supplier relationships: Existing contracts and established sourcing networks helped moderate short-term price fluctuations.
Logistics adjustments: Freight normalization and modest insurance changes created limited cost pressure without materially changing the overall market direction.
Procurement planning: Forecast-based purchasing and inventory management helped buyers reduce exposure to sudden cost changes.

Overall, the German Famotidine market demonstrated greater quarterly price stability than the markets in North America and APAC. Future price movements will depend on import availability, transportation costs, supplier quotations, and pharmaceutical procurement requirements.

Global Famotidine Price Comparison: Q2 2026

The regional market data for the quarter ending June 2026 highlights a relatively consistent pattern of modest logistics-driven price pressure in the United States and China, alongside stable conditions in Germany.

Region	Price Index Movement, QoQ	Average Quarterly Price
United States	+1.75%	USD 58,549.33/MT
China	+1.75%	USD 58,402.67/MT
Germany	Broadly stable	Exact average not provided

The United States recorded the highest reported average price among the two regions with available numerical data. China's average was slightly lower, although both markets experienced the same percentage increase in their respective price indices. These differences can reflect distinct supplier quotations, delivery terms, shipment costs, and regional procurement arrangements.

The comparison also demonstrates why the Famotidine price trend should not be evaluated solely through manufacturing costs. Transportation and insurance expenses can influence delivered prices even when the underlying pharmaceutical ingredient market remains relatively balanced.

Book A Demo for Famotidine Prices: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Famotidine

Key Factors Affecting the Global Famotidine Price Trend

Freight and Transportation Costs

Freight expenses were among the most important factors influencing Famotidine prices in Q2 2026. Pharmaceutical ingredients frequently move through international supply chains, making transportation costs a relevant component of the delivered purchase price.

Higher shipping charges can increase the landed cost for importers, while lower freight rates can provide relief. The impact depends on shipment size, delivery terms, transport routes, and the allocation of transportation responsibilities between suppliers and buyers.

Shipping Insurance and Risk-Related Expenses

Insurance costs also influenced market pricing during the quarter, particularly in China. Insurance premiums may vary according to shipment characteristics, route conditions, contractual arrangements, and perceived transportation risks.

When insurance costs rise, exporters and importers may renegotiate quotations or adjust their procurement budgets. The effect on the final Famotidine price depends on whether the supplier or buyer bears these expenses under the applicable delivery terms.

Pharmaceutical Demand and Procurement

Famotidine demand is connected to the production of medicines used to manage acid-related gastrointestinal conditions. Pharmaceutical companies purchase APIs according to production schedules, expected sales, inventory targets, and regulatory requirements.

Stable demand can support predictable procurement, whereas concentrated purchasing or unexpected replenishment requirements may create temporary pressure on available supplies. However, the supplied Q2 2026 observations indicate that logistics-related expenses were a major factor behind the reported increases in the United States and China.

Supplier Competition and Production Economics

Manufacturing efficiency, raw material availability, energy expenses, labor costs, quality-control requirements, and plant utilization can influence API pricing. Supplier competition may limit the extent to which higher costs are transferred to buyers, especially where multiple qualified suppliers are available.

Pharmaceutical buyers must also balance price competitiveness with quality assurance, consistency, documentation, and dependable delivery. These considerations can affect supplier selection and the final negotiated price.

Inventory and Contract Management

Inventory strategies influence the timing and size of procurement orders. Buyers with adequate safety stocks may be able to delay purchases during temporary price increases, while manufacturers with limited inventories may need to accept prevailing market quotations.

Long-term agreements, fixed-price contracts, and freight-inclusive arrangements can reduce short-term exposure to logistics volatility. Conversely, contracts that allow frequent cost adjustments may transmit changing freight and insurance expenses more quickly into purchase prices.

Famotidine Supply Chain and Market Outlook

The global Famotidine supply chain connects pharmaceutical ingredient manufacturers, exporters, importers, formulation producers, distributors, and healthcare-related procurement channels. Each stage can contribute to the final price through manufacturing, testing, packaging, storage, transportation, and compliance-related expenses.

For buyers, evaluating the full landed cost is therefore essential. A lower ex-works or FOB quotation does not necessarily result in the lowest delivered price if freight, insurance, handling, and other import expenses are higher. Comparing offers on a consistent commercial basis can provide a more accurate assessment of supplier competitiveness.

During Q2 2026, the United States and China recorded identical quarterly index increases, but their average prices differed slightly. Germany, meanwhile, maintained a broadly stable market environment. These developments underline the importance of regional sourcing strategies and close monitoring of logistics conditions.

Pharmaceutical companies may benefit from diversifying qualified suppliers, reviewing freight arrangements, monitoring shipment lead times, and maintaining appropriate inventory buffers. Such measures can help limit procurement uncertainty without compromising quality or continuity of supply.

Famotidine Prices Forecast: H2 2026

The Famotidine price outlook for the second half of 2026 will depend on transportation expenses, shipping insurance, import availability, pharmaceutical demand, and supplier pricing strategies. The supplied Q2 figures establish a baseline of moderate upward pressure in the United States and China, while Germany's market remains broadly stable.

If freight rates and insurance expenses ease, the upward pressure observed in North America and APAC could moderate. More predictable logistics costs may help importers negotiate stable quotations and improve procurement planning. However, any renewed increase in shipping expenses could continue to affect landed prices, particularly for buyers dependent on international sourcing.

In Germany, stable import flows and consistent procurement could continue to support a relatively balanced market. Changes in freight arrangements or supplier quotations may still influence individual transactions, but the overall direction will depend on whether logistics adjustments become more substantial.

Demand-side developments will also remain important. Pharmaceutical manufacturers will continue to align purchases with production requirements, stock availability, and anticipated orders. Changes in procurement volumes could affect supplier negotiations, although no specific demand-driven price increase or decrease can be established from the supplied quarterly data alone.

For the remainder of 2026, buyers should monitor freight and insurance quotations, supplier availability, contract renewal dates, and inventory requirements. A combination of these indicators will provide a more useful basis for procurement decisions than relying exclusively on historical price movements.

Because no numerical forecasts or verified forward price quotations were provided, a specific percentage increase or decrease for H2 2026 cannot be stated reliably.

Conclusion: Famotidine Price Analysis for Q2 2026

The Famotidine prices market in Q2 2026 experienced modest regional differences, with logistics-related costs emerging as a key pricing influence. The United States recorded an average price of USD 58,549.33/MT, following a 1.75% quarter-over-quarter increase. China reported an average of USD 58,402.67/MT, also reflecting a 1.75% increase, while Germany maintained broadly stable market conditions.

Freight increases and higher shipping insurance expenses contributed to the upward movement in North America and APAC. In Europe, predictable import flows and steady OTC and hospital procurement helped offset modest landed-cost adjustments.

Looking forward, freight rates, insurance premiums, supplier competition, import availability, and pharmaceutical procurement patterns will remain important indicators for the Famotidine price trend. Manufacturers and buyers can manage cost uncertainty through supplier diversification, careful contract evaluation, and improved inventory planning.

About Us:

Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

Contact Us:

Address:

420 Lexington Avenue, Suite 300 New York, NY 10170 United States

Phone: +1 332 258 6602

Email: [email protected]

Website: https://www.chemanalyst.com/

LinkedIn: https://www.linkedin.com/company/chemanalyst/

Facebook: https://www.facebook.com/ChemAnalysts/

Twitter: https://x.com/chemanalysts

YouTube: https://www.youtube.com/@chemanalyst

Instagram: https://www.instagram.com/chemanalyst_